{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T18:55:29Z","timestamp":1794855329999,"version":"4.9.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T00:00:00Z","timestamp":1739577600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"DOI":"10.1186\/s12933-025-02615-w","type":"journal-article","created":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:51:57Z","timestamp":1739598717000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Predicting major adverse cardiac events in diabetes and chronic kidney disease: a machine learning study from the Silesia Diabetes-Heart Project"],"prefix":"10.1186","volume":"24","author":[{"given":"Hanna","family":"Kwiendacz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliwia","family":"Janota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Irlik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yalin","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirela","family":"Hendel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Pia\u015bnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiktoria","family":"W\u00f3jcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uazman","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janusz","family":"Gumprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y. H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Nabrdalik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,15]]},"reference":[{"issue":"12","key":"2615_CR1","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.2337\/dci22-0027","volume":"45","author":"IH de Boer","year":"2022","unstructured":"de Boer IH, Khunti K, Sadusky T, Tuttle KR, Neumiller JJ, Rhee CM, et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and kidney disease: improving global outcomes (KDIGO). Diabetes Care. 2022;45(12):3075\u201390. https:\/\/doi.org\/10.2337\/dci22-0027.","journal-title":"Diabetes Care"},{"issue":"11","key":"2615_CR2","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1093\/ckj\/sfad194","volume":"16","author":"J Ruhe","year":"2023","unstructured":"Ruhe J, Nadal J, Barthlein B, Meiselbach H, Schultheiss UT, Kotsis F, et al. Cardiovascular risk due to diabetes mellitus in patients with chronic kidney disease-prospective data from the German chronic kidney disease cohort. Clin Kidney J. 2023;16(11):2032\u201340. https:\/\/doi.org\/10.1093\/ckj\/sfad194.","journal-title":"Clin Kidney J"},{"issue":"3","key":"2615_CR3","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jacc.2007.03.037","volume":"50","author":"DE Weiner","year":"2007","unstructured":"Weiner DE, Tighiouart H, Elsayed EF, Griffith JL, Salem DN, Levey AS, et al. The Framingham predictive instrument in chronic kidney disease. J Am Coll Cardiol. 2007;50(3):217\u201324. https:\/\/doi.org\/10.1016\/j.jacc.2007.03.037.","journal-title":"J Am Coll Cardiol"},{"key":"2615_CR4","doi-asserted-by":"publisher","unstructured":"Ahmad A, Lim LL, Morieri ML, Tam CH, Cheng F, Chikowore T et al. Precision prognostics for cardiovascular disease in Type 2 diabetes: a systematic review and meta-analysis. Commun Med (Lond). 2024;4(1):11. https:\/\/doi.org\/10.1038\/s43856-023-00429-z.","DOI":"10.1038\/s43856-023-00429-z"},{"issue":"11","key":"2615_CR5","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s13300-020-00923-w","volume":"11","author":"M Willis","year":"2020","unstructured":"Willis M, Asseburg C, Slee A, Nilsson A, Neslusan C. Development and internal validation of a discrete event simulation model of diabetic kidney disease using CREDENCE trial data. Diabetes Ther. 2020;11(11):2657\u201376. https:\/\/doi.org\/10.1007\/s13300-020-00923-w.","journal-title":"Diabetes Ther"},{"issue":"4","key":"2615_CR6","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.ahj.2011.07.016","volume":"162","author":"JJ Mcmurray","year":"2011","unstructured":"Mcmurray JJ, Uno H, Jarolim P, Desai AS, de Zeeuw D, Eckardt KU, et al. Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: an analysis of the Trial to reduce cardiovascular events with Aranesp (darbepoetin-alfa) therapy (TREAT). Am Heart J. 2011;162(4):748\u201355. https:\/\/doi.org\/10.1016\/j.ahj.2011.07.016.","journal-title":"Am Heart J"},{"issue":"6","key":"2615_CR7","doi-asserted-by":"publisher","first-page":"784","DOI":"10.2337\/dc16-2175","volume":"40","author":"A Bidadkosh","year":"2017","unstructured":"Bidadkosh A, Lambooy S, Heerspink HJ, Pena MJ, Henning RH, Buikema H, et al. Predictive properties of biomarkers GDF-15, NTproBNP, and hs-TnT for morbidity and mortality in patients with type 2 diabetes with nephropathy. Diabetes Care. 2017;40(6):784\u201392. https:\/\/doi.org\/10.2337\/dc16-2175.","journal-title":"Diabetes Care"},{"issue":"1","key":"2615_CR8","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.jacc.2024.05.003","volume":"84","author":"R Khera","year":"2024","unstructured":"Khera R, Oikonomou EK, Nadkarni GN, Morley JR, Wiens J, Butte AJ, et al. Transforming cardiovascular care with Artificial Intelligence: from discovery to practice: JACC state-of-the-art review. J Am Coll Cardiol. 2024;84(1):97\u2013114. https:\/\/doi.org\/10.1016\/j.jacc.2024.05.003.","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"2615_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1007\/s12178-020-09600-8","volume":"13","author":"JM Helm","year":"2020","unstructured":"Helm JM, Swiergosz AM, Haeberle HS, Karnuta JM, Schaffer JL, Krebs VE, et al. Machine learning and Artificial Intelligence: definitions, applications, and future directions. Curr Rev Musculoskelet Med. 2020;13(1):69\u201376. https:\/\/doi.org\/10.1007\/s12178-020-09600-8.","journal-title":"Curr Rev Musculoskelet Med"},{"key":"2615_CR10","doi-asserted-by":"publisher","unstructured":"Kokori E, Patel R, Olatunji G, Ukoaka BM, Abraham IC, Ajekiigbe VO et al. Machine learning in predicting heart failure survival: a review of current models and future prospects. Heart Fail Rev. 2024. https:\/\/doi.org\/10.1007\/s10741-024-10474-y.","DOI":"10.1007\/s10741-024-10474-y"},{"key":"2615_CR11","doi-asserted-by":"publisher","first-page":"1390729","DOI":"10.3389\/fendo.2024.1390729","volume":"15","author":"H Zhu","year":"2024","unstructured":"Zhu H, Qiao S, Zhao D, Wang K, Wang B, Niu Y, et al. Machine learning model for cardiovascular disease prediction in patients with chronic kidney disease. Front Endocrinol (Lausanne). 2024;15:1390729. https:\/\/doi.org\/10.3389\/fendo.2024.1390729.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"7","key":"2615_CR12","doi-asserted-by":"publisher","first-page":"101694","DOI":"10.1016\/j.cpcardiol.2023.101694","volume":"48","author":"K Nabrdalik","year":"2023","unstructured":"Nabrdalik K, Kwiendacz H, Drozdz K, Irlik K, Hendel M, Wijata AM, et al. Machine learning predicts cardiovascular events in patients with diabetes: the Silesia Diabetes-Heart Project. Curr Probl Cardiol. 2023;48(7):101694. https:\/\/doi.org\/10.1016\/j.cpcardiol.2023.101694.","journal-title":"Curr Probl Cardiol"},{"key":"2615_CR13","doi-asserted-by":"publisher","unstructured":"Kwiendacz H, Wijata AM, Nalepa J, Piasnik J, Kulpa J, Herba M et al. Machine learning profiles of cardiovascular risk in patients with diabetes mellitus: the Silesia Diabetes-Heart Project. Cardiovasc Diabetol. 2023;22(1):218. https:\/\/doi.org\/10.1186\/s12933-023-01938-w.","DOI":"10.1186\/s12933-023-01938-w"},{"issue":"4","key":"2615_CR14","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1093\/ckj\/sfz094","volume":"13","author":"C Forne","year":"2020","unstructured":"Forne C, Cambray S, Bermudez-Lopez M, Fernandez E, Bozic M, Valdivielso JM. Machine learning analysis of serum biomarkers for cardiovascular risk assessment in chronic kidney disease. Clin Kidney J. 2020;13(4):631\u201339. https:\/\/doi.org\/10.1093\/ckj\/sfz094.","journal-title":"Clin Kidney J"},{"issue":"2","key":"2615_CR15","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1093\/bib\/bbx124","volume":"20","author":"F Degenhardt","year":"2019","unstructured":"Degenhardt F, Seifert S, Szymczak S. Evaluation of variable selection methods for random forests and omics data sets. Brief Bioinform. 2019;20(2):492\u2013503. https:\/\/doi.org\/10.1093\/bib\/bbx124.","journal-title":"Brief Bioinform"},{"key":"2615_CR16","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.jbi.2015.11.012","volume":"59","author":"I Kamkar","year":"2016","unstructured":"Kamkar I, Gupta SK, Phung D, Venkatesh S. Stabilizing l1-norm prediction models by supervised feature grouping. J Biomed Inf. 2016;59:149\u201368. https:\/\/doi.org\/10.1016\/j.jbi.2015.11.012.","journal-title":"J Biomed Inf"},{"key":"2615_CR17","doi-asserted-by":"publisher","first-page":"103502","DOI":"10.1016\/j.artint.2021.103502","volume":"298","author":"K Aas","year":"2021","unstructured":"Aas K, Jullum M, L\u00f8land A. Explaining individual predictions when features are dependent: more accurate approximations to Shapley values. Artif Intell. 2021;298:103502.","journal-title":"Artif Intell"},{"key":"2615_CR18","doi-asserted-by":"publisher","first-page":"923549","DOI":"10.3389\/fcvm.2022.923549","volume":"9","author":"J Ren","year":"2022","unstructured":"Ren J, Liu D, Li G, Duan J, Dong J, Liu Z. Prediction and risk stratification of cardiovascular disease in diabetic kidney disease patients. Front Cardiovasc Med. 2022;9:923549. https:\/\/doi.org\/10.3389\/fcvm.2022.923549.","journal-title":"Front Cardiovasc Med"},{"issue":"5","key":"2615_CR19","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1007\/s10439-024-03459-3","volume":"52","author":"VA Binson","year":"2024","unstructured":"Binson VA, Thomas S, Subramoniam M, Arun J, Naveen S, Madhu S. A review of machine learning algorithms for biomedical applications. Ann Biomed Eng. 2024;52(5):1159\u201383. https:\/\/doi.org\/10.1007\/s10439-024-03459-3.","journal-title":"Ann Biomed Eng"},{"issue":"1","key":"2615_CR20","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s12911-019-1004-8","volume":"19","author":"S Uddin","year":"2019","unstructured":"Uddin S, Khan A, Hossain ME, Moni MA. Comparing different supervised machine learning algorithms for disease prediction. BMC Med Inf Decis Mak. 2019;19(1):281. https:\/\/doi.org\/10.1186\/s12911-019-1004-8.","journal-title":"BMC Med Inf Decis Mak"},{"key":"2615_CR21","doi-asserted-by":"publisher","unstructured":"Rufo DD, Debelee TG, Ibenthal A, Negera WG. Diagnosis of diabetes mellitus using gradient boosting machine (LightGBM). Diagnostics (Basel). 2021;11(9). https:\/\/doi.org\/10.3390\/diagnostics11091714.","DOI":"10.3390\/diagnostics11091714"},{"key":"2615_CR22","doi-asserted-by":"publisher","unstructured":"Yu KH, Beam AL, Kohane IS. Artificial intelligence in healthcare. Nat Biomed Eng. 2018;2(10):719\u2013\u200931. https:\/\/doi.org\/10.1038\/s41551-018-0305-z.","DOI":"10.1038\/s41551-018-0305-z"},{"key":"2615_CR23","doi-asserted-by":"publisher","first-page":"107555","DOI":"10.1016\/j.compbiomed.2023.107555","volume":"166","author":"S Ali","year":"2023","unstructured":"Ali S, Akhlaq F, Imran AS, Kastrati Z, Daudpota SM, Moosa M. The enlightening role of explainable artificial intelligence in medical & healthcare domains: a systematic literature review. Comput Biol Med. 2023;166:107555. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107555.","journal-title":"Comput Biol Med"},{"key":"2615_CR24","doi-asserted-by":"publisher","unstructured":"Dharmarathne G, Bogahawaththa M, Mcafee M, Rathnayake U, Meddage D. On the diagnosis of chronic kidney disease using a machine learning-based interface with explainable artificial intelligence. Intell Syst Appl. 2024;22. https:\/\/doi.org\/10.1016\/j.iswa.2024.200397.","DOI":"10.1016\/j.iswa.2024.200397"},{"key":"2615_CR25","doi-asserted-by":"publisher","unstructured":"Dharmarathne G, Bogahawaththa M, Rathnayake U, Meddage D. Integrating explainable machine learning and user-centric model for diagnosing cardiovascular disease: a novel approach. Intell Syst Appl. 2024;23. https:\/\/doi.org\/10.1016\/j.iswa.2024.200428.","DOI":"10.1016\/j.iswa.2024.200428"},{"key":"2615_CR26","doi-asserted-by":"publisher","unstructured":"Dharmarathne G, Jayasinghe T, Bogahawaththa M, Meddage D, Rathnayake U. A novel machine learning approach for diagnosing diabetes with a self-explainable interface. Healthc Anal. 2024;5. https:\/\/doi.org\/10.1016\/j.health.2024.100301.","DOI":"10.1016\/j.health.2024.100301"},{"key":"2615_CR27","unstructured":"Filho M. How To Get Feature Importance In LightGBM (Python example). https:\/\/forecastegy.com\/posts\/feature-importance-lightgbm-python-example\/ 2023."},{"key":"2615_CR28","unstructured":"Bhatt N. Shap feature importance deep dive. https:\/\/medium.com\/@bneeraj026\/shap-feature-importance-deep-dive-1b96a9d43d082023."},{"issue":"4","key":"2615_CR29","doi-asserted-by":"publisher","first-page":"e123116","DOI":"10.1371\/journal.pone.0123116","volume":"10","author":"YY Chen","year":"2015","unstructured":"Chen YY, Lin YJ, Chong E, Chen PC, Chao TF, Chen SA, et al. The impact of diabetes mellitus and corresponding HbA1c levels on the future risks of cardiovascular disease and mortality: a representative cohort study in Taiwan. PLoS ONE. 2015;10(4):e123116. https:\/\/doi.org\/10.1371\/journal.pone.0123116.","journal-title":"PLoS ONE"},{"issue":"1","key":"2615_CR30","doi-asserted-by":"publisher","first-page":"104","DOI":"10.2337\/dc17-1669","volume":"41","author":"AK Lee","year":"2018","unstructured":"Lee AK, Warren B, Lee CJ, Mcevoy JW, Matsushita K, Huang ES, et al. The association of severe hypoglycemia with incident cardiovascular events and mortality in adults with type 2 diabetes. Diabetes Care. 2018;41(1):104\u201311. https:\/\/doi.org\/10.2337\/dc17-1669.","journal-title":"Diabetes Care"},{"issue":"10","key":"2615_CR31","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1002\/clc.24104","volume":"46","author":"Y Wang","year":"2023","unstructured":"Wang Y, Hou R, Ni B, Jiang Y, Zhang Y. Development and validation of a prediction model based on machine learning algorithms for predicting the risk of heart failure in middle-aged and older US people with prediabetes or diabetes. Clin Cardiol. 2023;46(10):1234\u201343. https:\/\/doi.org\/10.1002\/clc.24104.","journal-title":"Clin Cardiol"},{"key":"2615_CR32","doi-asserted-by":"publisher","first-page":"107289","DOI":"10.1016\/j.compbiomed.2023.107289","volume":"164","author":"TM Abegaz","year":"2023","unstructured":"Abegaz TM, Baljoon A, Kilanko O, Sherbeny F, Ali AA. Machine learning algorithms to predict major adverse cardiovascular events in patients with diabetes. Comput Biol Med. 2023;164:107289. https:\/\/doi.org\/10.1016\/j.compbiomed.2023.107289.","journal-title":"Comput Biol Med"},{"issue":"3","key":"2615_CR33","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1159\/000538510","volume":"10","author":"Y Wang","year":"2024","unstructured":"Wang Y, Shi Y, Xiao T, Bi X, Huo Q, Wang S, et al. A Klotho-based machine learning model for prediction of both kidney and cardiovascular outcomes in chronic kidney disease. Kidney Dis (Basel). 2024;10(3):200\u201312. https:\/\/doi.org\/10.1159\/000538510.","journal-title":"Kidney Dis (Basel)"},{"issue":"1","key":"2615_CR34","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/HJH.0000000000002982","volume":"40","author":"BC Jaeger","year":"2022","unstructured":"Jaeger BC, Sakhuja S, Hardy ST, Akinyelure OP, Bundy JD, Muntner P, et al. Predicted cardiovascular risk for United States adults with diabetes, chronic kidney disease, and at least 65 years of age. J Hypertens. 2022;40(1):94\u2013101. https:\/\/doi.org\/10.1097\/HJH.0000000000002982.","journal-title":"J Hypertens"},{"issue":"1","key":"2615_CR35","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12933-023-02008-x","volume":"22","author":"A Ramezankhani","year":"2023","unstructured":"Ramezankhani A, Azizi F, Hadaegh F. Association between estimated glomerular filtration rate slope and cardiovascular disease among individuals with and without diabetes: a prospective cohort study. Cardiovasc Diabetol. 2023;22(1):270. https:\/\/doi.org\/10.1186\/s12933-023-02008-x.","journal-title":"Cardiovasc Diabetol"},{"key":"2615_CR36","doi-asserted-by":"publisher","unstructured":"Tao LC, Xu JN, Wang TT, Hua F, Li JJ. Triglyceride-glucose index as a marker in cardiovascular diseases: landscape and limitations. Cardiovasc Diabetol. 2022;21(1):68. https:\/\/doi.org\/10.1186\/s12933-022-01511-x.","DOI":"10.1186\/s12933-022-01511-x"},{"issue":"1","key":"2615_CR37","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12933-023-02054-5","volume":"22","author":"J Chen","year":"2023","unstructured":"Chen J, Wu K, Lin Y, Huang M, Xie S. Association of triglyceride glucose index with all-cause and cardiovascular mortality in the general population. Cardiovasc Diabetol. 2023;22(1):320. https:\/\/doi.org\/10.1186\/s12933-023-02054-5.","journal-title":"Cardiovasc Diabetol"},{"issue":"1","key":"2615_CR38","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1186\/s12933-022-01599-1","volume":"21","author":"S Tai","year":"2022","unstructured":"Tai S, Fu L, Zhang N, Yang R, Zhou Y, Xing Z, et al. Association of the cumulative triglyceride-glucose index with major adverse cardiovascular events in patients with type 2 diabetes. Cardiovasc Diabetol. 2022;21(1):161. https:\/\/doi.org\/10.1186\/s12933-022-01599-1.","journal-title":"Cardiovasc Diabetol"},{"issue":"9","key":"2615_CR39","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.1093\/ckj\/sfac073","volume":"15","author":"B Quiroga","year":"2022","unstructured":"Quiroga B, Munoz RP, Sanchez HA, Ortiz A, Valdivieso JM, Carrero JJ. Triglycerides-glucose index and the risk of cardiovascular events in persons with non-diabetic chronic kidney disease. Clin Kidney J. 2022;15(9):1705\u201312. https:\/\/doi.org\/10.1093\/ckj\/sfac073.","journal-title":"Clin Kidney J"},{"issue":"11","key":"2615_CR40","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1111\/cts.70056","volume":"17","author":"AV Ponce-Bobadilla","year":"2024","unstructured":"Ponce-Bobadilla AV, Schmitt V, Maier CS, Mensing S, Stodtmann S. Practical guide to SHAP analysis: explaining supervised machine learning model predictions in drug development. Clin Transl Sci. 2024;17(11):e70056. https:\/\/doi.org\/10.1111\/cts.70056.","journal-title":"Clin Transl Sci"},{"issue":"1","key":"2615_CR41","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1186\/s12933-024-02367-z","volume":"23","author":"K Nabrdalik","year":"2024","unstructured":"Nabrdalik K, Irlik K, Meng Y, Kwiendacz H, Piasnik J, Hendel M, et al. Artificial intelligence-based classification of cardiac autonomic neuropathy from retinal fundus images in patients with diabetes: the Silesia Diabetes Heart Study. Cardiovasc Diabetol. 2024;23(1):296. https:\/\/doi.org\/10.1186\/s12933-024-02367-z.","journal-title":"Cardiovasc Diabetol"},{"key":"2615_CR42","doi-asserted-by":"publisher","unstructured":"Chowdhury M, Nevitt S, Eleftheriadou A, Kanagala P, Esa H, Cuthbertson DJ, et al. Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis. BMJ Open Diabetes Res Care. 2021;9(2). https:\/\/doi.org\/10.1136\/bmjdrc-2021-002480.","DOI":"10.1136\/bmjdrc-2021-002480"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02615-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12933-025-02615-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-025-02615-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,15]],"date-time":"2025-02-15T05:52:01Z","timestamp":1739598721000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-025-02615-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,15]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2615"],"URL":"https:\/\/doi.org\/10.1186\/s12933-025-02615-w","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,15]]},"assertion":[{"value":"20 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Based on the decision of the Bioethics Committee of the Medical University of Silesia in Katowice, the need for ethical approval was waived (decision no. PCN\/0022\/KB\/126\/20).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors gave consent for the publication of the article.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"G.L. is a consultant and speaker for BMS\/Pfizer, Boehringer Ingelheim, Anthos and Daiichi-Sankyo. No fees are received personally. G.L. is a NIHR Senior Investigator and co-PI of the AFFIRMO project on multimorbidity in AF (grant agreement No 899871), TARGET project on digital twins for personalised management of atrial fibrillation and stroke (grant agreement No 101136244) and ARISTOTELES project on artificial intelligence for management of chronic long term conditions (grant agreement No 101080189), which are all funded by the EU\u2019s Horizon Europe Research & Innovation program. U.A. has received investigator-led funding form Proctor & Gamble. U.A. has received honoraria from Viatris, Gr\u00fcnenthal, Eli Lilly, Procter & Gamble, and Sanofi for educational meetings. U.A. has received funding for attendance to an international medical conference from Diiachi Sankyo. U.A. is member of the Royal Society of Medicine\u2019s Vascular, Lipid & Metabolic Medicine Section (Unpaid). K.N. received remunerations\/fees for activities on behalf of Sanofi Aventis, Eli Lilly, Novo Nordisk, Astra-Zeneca, Boehringer-Ingelheim and received support for attending meetings and\/or travel from Sanofi Aventis. H.K. received remunerations\/fees for activities on behalf of Sanofi Aventis, Eli Lilly, Novo Nordisk, Astra-Zeneca, Boehringer-Ingelheim and received support for attending meetings and\/or travel from Sanofi Aventis. Others declared none conflict of interest.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"76"}}